T-Cell Non-Hodgkin Lymphoma — Trials

T-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

1,008 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 225
Recruiting: 127
Ph III recruiting: 9
Growth YoY: +23.4%
Industry share: 21%
Top sponsor: Institute of Hematology & Blood Diseases Hospital, China
Termination share: 35.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (169)

clinicaltrialsPublishedShowing 751–800 of 1,008 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00038883	Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies	terminated	N/A	19	M.D. Anderson Cancer CenterOTHER	1	Nov 7, 2018	clinicaltrials
NCT00038376	Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies	completed	Phase 2	56	M.D. Anderson Cancer CenterOTHER	1	Oct 29, 2018	clinicaltrials